|
Fatty acid metabolism (hsa01212)
|
34
|
ACSL5, FASN, MCAT, ACADSB, ACSL3, PTPLB, ACOX1, PECR, ACOX3, HADH;
|
19
|
miR-124-3p, miR-142-5p, miR-27b-3p, miR-30a-5p, miR-181a-5p;
|
6.23e-08
|
|
Estrogen signaling pathway (hsa04915)
|
73
|
ESR1, BABBR1, FOS, HBEGF, ADCY1, SOS2, ATF2, ADCY7, NRAS, MAP2K2;
|
30
|
miR-103a-3p, miR-148a-3p, miR-27b-3p, miR-28-3p, miR-532-5p;
|
4.50e-06
|
|
Oocyte meiosis (hsa04114)
|
78
|
SLK, ESPL1, PPP1CA, FBXO5, CAMK2D, PPP2R5E, SMC1A, YWHAH, ADCY1, CCNB1;
|
30
|
miR-92b-3p, miR-30a-5p, miR-365a-3p, let-7i-5p, miR-708-5p;
|
0.00015
|
|
Endometrial cancer (hsa05213)
|
40
|
BRAF, GSK3B, ERBB2, SOS2, NRAS, MAP2K2, APC, PIK3CB, TCF7L2, RAF1;
|
27
|
miR-138-5p, miR-181b-5p, miR-126-3p, miR-146a-5p, miR-676-3p;
|
0.00108
|
|
Progesterone-mediated oocyte maturation (hsa04914)
|
65
|
BRAF, ADCY1, CCNB1, PGR, CCNA7, BUB1, FZR1, GNAI3, ANAPC2, ARAF;
|
29
|
miR-592, let-7b-5p, miR-124-3p, miR-181a-5p, miR-30e-5p;
|
0.00116
|
|
Prolactin signaling pathway (hsa04917)
|
52
|
ESR1, PRLR, FOS, GSK3B, STAT3, NFKB1, SOCS4, SOS2, CISH, JAK2;
|
28
|
miR-490-3p, let-7i-5p, miR-124-3p, miR-191-5p;
|
0.00221
|
|
Long-term depression (hsa04730)
|
39
|
BRAF, PRKCA, GNA12, NRAS, GNAS, GNA13, PLA2G4F, GNAQ, ITPR3;
|
29
|
miR-124-3p, miR-92b-3p, miR-365a-3p, miR-708-5p, miR-181a-5p;
|
0.00420
|
|
Steroid biosynthesis (hsa00100)
|
14
|
SS5D, TM7SF2, MSMO1, DHCR24, CYP51A1, SOAT1, LSS, SQLE;
|
21
|
miR-30a-5p, miR-30b-5p, miR-30e-5p, miR-148a-3p;
|
0.00709
|
|
Axon guidance (hsa04360)
|
78
|
EFNB2, SEMA6A, PLXNA2, GSK3B, MET, ROCK1, L1CAM, FES, RHOA;
|
30
|
miR-124-3p, miR-148a-3p, miR-676-3p, miR-99b-5p;
|
0.04447
|
